Dendreon
1700 Saturn Way
Seal Beach
CA
90740
United States
Tel: 206-256-4545
Fax: 206-256-0571
Website: http://www.dendreon.com/
322 articles about Dendreon
-
Dendreon Corporation To Host Conference Call On March 3 To Announce Fourth Quarter And Full Year 2013 Financial Results
2/17/2014
-
Dendreon Corporation Announces Presentation Of PROVENGE® (sipuleucel-T) Data At The 2014 Genitourinary Cancer Symposium (ASCO GU)
1/30/2014
-
Dendreon Corporation Announces Preliminary Fourth Quarter 2013 Revenues
1/13/2014
-
Dendreon Corporation Announces Change To Presentation Date And Time At J.P. Morgan Healthcare Conference
1/10/2014
-
Dendreon Corporation Announces Webcast Presentation At J.P. Morgan Healthcare Conference
1/8/2014
-
Dendreon Corporation's Provenge Vaccine, A Hedge Fund Manager And The SEC
12/4/2013
-
Dendreon Corporation Announces Webcast Presentation at Deutsche Bank BioFEST Conference
11/27/2013
-
Dendreon Corporation Slashes 15 Percent Of Jobs As Provenge Sales Disappoint
11/13/2013
-
Dendreon Corporation Announces Third Quarter 2013 Results
11/12/2013
-
Drug Maker Dendreon Corporation Seeking a Buyer
10/28/2013
-
PharmaCell BV Announces Agreement to be the European Contract Manufacturing Organization for Dendreon Corporation
10/23/2013
-
Dendreon Corporation to Host Conference Call on November 12 to Announce Third Quarter Financial Results
10/8/2013
-
Dendreon Corporation Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2013 European Cancer Congress
9/27/2013
-
Dendreon Corporation Announces Marketing Authorization for PROVENGE® in the European Union
9/17/2013
-
Dendreon Corporation Announces Second Quarter 2013 Results
8/9/2013
-
Dendreon Corporation to Host Conference Call on August 8 to Announce Second Quarter Financial Results
7/16/2013
-
Dendreon Corporation Surges After Cancer Drug Gets European Backing, Stock Up +0.1701 (4.17%) @10:07 AM ET
6/28/2013
-
Dendreon Corporation Announces Presentation of PROVENGE® (sipuleucel-T) Data at the 2013 American Society of Clinical Oncology Annual Meeting
5/31/2013
-
Dendreon Corporation Announces First Quarter 2013 Results
5/9/2013
-
Dendreon Corporation Release: PROVENGE® (sipuleucel-T) Data Presented at an Annual Scientific Urology Meeting
5/7/2013